Apexigen SPAC Presentation Deck
March 2022, 28 slides
  1. Apexigen
  2. Related Decks
  3. SPAC Presentation Decks
combination of and capital acquisition corp | Apexigen
disclaimer statements | Apexigen
capital acquisition corp overview | Apexigen
overview of merger pipe and equity line transactions | Apexigen
transaction overview capitalization sources and uses | Apexigen
management team with deep and seasoned investors immune design cancer | Apexigen
| Apexigen
robust pipeline and partnerships | Apexigen
lead product | Apexigen
targeting a key pathway in stimulating immune response in cancer | Apexigen
potentially first in class and best in class agonist antibody | Apexigen
highlights of phase clinical development program at | Apexigen
focused on high priority phase combination trials | Apexigen
anti tumor effects of in melanoma single agent and anti combination efficacy is yor | Apexigen
meaningful data in esophageal study of combination ongoing | Apexigen
durable responses in sarcoma advanced soft tissue study of combination ongoing | Apexigen
studies of in other indications and combinations | Apexigen
summary of program | Apexigen
| Apexigen
reverse immune suppression in and unleash immune mediated tumor killing | Apexigen
potent anti tumor activity in preclinical models | Apexigen
platform | Apexigen
our unique antibody discovery platform | Apexigen
summary | Apexigen
near term key milestones | Apexigen
| Apexigen
additional disclaimer statements | Apexigen
additional disclaimer statements | Apexigen
See More
Apexigen
SPAC Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Melanoma
Tumor
Cancer
Antibody discovery
Recent decks by Apexigen
Investor Presentation
September 2022
See all presentations by Apexigen (2 decks)
Related decks
BioAtla
Investor Conference
June 2022
Immatics
Investor Presentation
November 2023
Erasca
Investor Presentation
November 2023
Alkermes
Results
June 2022
Immatics
Results
October 2022
BioNTech
Results
May 2021
BioNTech
Results
August 2020
BioAtla
Investor Presentation
January 2024
Recent decks by Apexigen
See all presentations (2 decks)
Investor Presentation
September 2022
BioAtla
Investor Conference
June 2022
Immatics
Investor Presentation
November 2023
Erasca
Investor Presentation
November 2023
Alkermes
Results
June 2022
Immatics
Results
October 2022
BioNTech
Results
May 2021
BioNTech
Results
August 2020
BioAtla
Investor Presentation
January 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights